SUBSCRIBE
SUBSCRIBE
News   Deals

QLT Inc. Gets Rights to Sell Visudyne in US from Novartis Pharma AG (JOBS)

October 19, 2009 | 
1 min read
Bookmark and Share

Reuters -- Canadian eye-care company QLT Inc said it restructured its pact with Novartis Pharma AG, giving it exclusive rights to sell anti-blindness treatment Visudyne in the United States.
Mergers & acquisitions
MORE ON THIS TOPIC
Business and HR concepts for leaders and teams. Circular wooden blocks with hand icons printed on them are connected to wooden blocks with business people icons printed on them. Teamwork concept, business concept
Mergers & acquisitions
Revolution, Ascendis Named Top Buyout Targets as Industry Awaits The Big One
March 19, 2026
 · 
2 min read
 · 
Tristan Manalac
Confrontation and opposite opinions concept. Business people hands pulling rope in opposite directions in office showing power and leadership vector illustration
Mergers & acquisitions
Pharma Is Ravenous for M&A Action but Late-Stage Supply Dwindles
March 11, 2026
 · 
5 min read
 · 
Annalee Armstrong
Brain tumor medical poster. Cancer, metastasis or benign in the human head or in the nerves, pituitary gland, pineal gland, and membranes that cover the surface of the brain 3D vector illustration
Mergers & acquisitions
Servier Adds to Childhood Brain Tumor Portfolio With $2.5B Day One Buy
March 6, 2026
 · 
1 min read
 · 
Annalee Armstrong
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Cardiovascular disease
Alnylam Unites With Tenaya in Potential $1B+ Pact To Find New Genetic Heart Disease Targets
March 5, 2026
 · 
2 min read
 · 
Heather McKenzie